4//SEC Filing
Bartushak Jaime 4
Accession 0001213900-24-096893
CIK 0001506251other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:00 PM ET
Size
18.2 KB
Accession
0001213900-24-096893
Insider Transaction Report
Form 4
Bartushak Jaime
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase Common Stock)
2024-11-07+350,000→ 350,000 totalExercise: $0.38Exp: 2034-11-07→ Common Stock (350,000 underlying)
Holdings
- 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.70Exp: 2033-10-10→ Common Stock (300,000 underlying) - 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.25Exp: 2032-10-04→ Common Stock (300,000 underlying) - 70,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.62Exp: 2028-09-04→ Common Stock (70,000 underlying) - 25,000
Stock Option (Right to Purchase Common Stock)
Exercise: $3.45Exp: 2027-09-15→ Common Stock (25,000 underlying) - 48,267
Stock Option (Right to Purchase Common Stock)
Exercise: $10.50Exp: 2026-07-06→ Common Stock (48,267 underlying) - 125,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.01Exp: 2030-10-06→ Common Stock (125,000 underlying) - 60,353
Common Stock
- 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (300,000 underlying) - 100,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (100,000 underlying) - 100,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.67Exp: 2029-10-08→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date
- [F2]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
- [F3]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
- [F4]The options are vested in full and exercisable immediately.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001725077
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:00 PM ET
- Size
- 18.2 KB